$UROV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Urovant Sciences Ltd.. Get notifications about new insider transactions in Urovant Sciences Ltd. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,732,710 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 28 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 28 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 0 | -4,802 to 0 (-100.00 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 9,995.00 | 9,995 | 99,900,025 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 23 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 22 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 22 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.39 | 1,714 | 14,375 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
Mar 05 2019 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | Director | Option Exercise | A | 12.41 | 50,000 | 620,500 | 50,000 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | McFadden Michael E. | CCO/Urovant Science ... | Option Exercise | A | 6.88 | 100,000 | 688,000 | 100,000 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Option Exercise | A | 6.88 | 70,000 | 481,600 | 70,000 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | A | 6.88 | 350,250 | 2,409,720 | 350,250 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | OCAMPO CHRISTINE | PFAO;CAO/Urovant Sc ... | Option Exercise | A | 6.88 | 70,000 | 481,600 | 70,000 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Option Exercise | A | 6.88 | 100,000 | 688,000 | 100,000 | |
Jan 08 2019 | UROV | Urovant Sciences L ... | Ebersole Nori | SVP;CHRO/Urovant Sc ... | Option Exercise | A | 6.88 | 65,000 | 447,200 | 65,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 8.01 | 50,000 | 400,500 | 50,000 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 13.65 | 99,967 | 1,364,550 | 99,967 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | Ebersole Nori | SVP&CHRO-Urovant Sc ... | Option Exercise | A | 13.65 | 3,000 | 40,950 | 3,000 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC of Urovant Scien ... | Option Exercise | A | 13.65 | 3,500 | 47,775 | 3,500 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO of Urovant Scie ... | Option Exercise | A | 13.65 | 1,000 | 13,650 | 1,000 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | McFadden Michael E. | CCO of Urovant Scie ... | Option Exercise | A | 13.65 | 4,750 | 64,838 | 4,750 | |
Oct 17 2018 | UROV | Urovant Sciences L ... | OCAMPO CHRISTINE | PFAO;CAO/Urovant Sc ... | Option Exercise | A | 13.65 | 3,750 | 51,188 | 3,750 | |
Oct 03 2018 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 3.86 | 200,250 | 772,965 | 200,250 | |
Oct 03 2018 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Sep 28 2018 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO-Urovant Sci ... | Option Exercise | A | 14.00 | 39,815 | 557,410 | 39,815 |